baber/WOPTO huggingface dataset:
Patent NZ-284192-A (NZ)
Title: Plant extract from the genus vaccinium with bacterial anti-adhesive activity and medicinal compositions
Inventor: WALKER EDWARD B
IPC: A23L29/269
Filed: 1995-03-24
Abstract: An extract prepared from plants of the genus Vaccinium, especially cranberries, which is enriched for an activity which inhibits bacterial adhesion to surfaces. The extract is also enriched for polyphenol and flavonoid compounds, lacks detectable amounts of simple sugars, has a very low content of benzoic acid relative to raw cranberries, and lacks significant amounts of anthocyanins. Methods for preparing and for using the extract are also disclosed.
Patent NZ-297513-A (NZ)
Title: Carbon dioxide sensitive material which changes colour when the carbon dioxide concentration changes
Inventor: BALDERSON SIMON NEVILLE
IPC: G01N31/22
Filed: 1995-12-19
Abstract: PCT No. PCT/GB95/02970 Sec. 371 Date May 16, 1997 Sec. 102(e) Date May 16, 1997 PCT Filed Dec. 19, 1995 PCT Pub. No. WO96/19727 PCT Pub. Date Jun. 27, 1996A carbon dioxide sensitive material including a polymer binder, a plasticiser, a lipophilic organic quaternary cation, an indicator dye anion and an aromatic alcohol in such concentration that the material changes color in accordance with the concentration of carbon dioxide.
Patent NZ-310339-A (NZ)
Title: Compositions for stimulating neurite growth comprising a neurotrophic amount of a compound with affinity for FKBP12 and a neurotrophic agent
Inventor: ARMISTEAD DAVID M
IPC: A61K31/4535
Filed: 1996-06-06
Abstract: The application relates to methods and pharmaceutical compositions for stimulating the growth of neurites in nerve cells.  The compositions comprise a neurotrophic amount of a compound which binds to the FK-506 binding protein (FKBP) and a neurotrophic factor, such as nerve growth factor NGF.  The methods comprise treating nerve cells with the above-described compositions or compositions comprising the FKBP binding compound without a neurotrophic factor.  These methods can be used to promote repair of neuronal damage caused by disease or physical trauma.
Patent NZ-325276-A (NZ)
Title: Microbial method of in vitro transformation of a steroid into the 11a-hydroxy analogue using oxygen and a micro-organism
Inventor: WIERSMA MARTEN
IPC: C12R1/685
Filed: 1996-12-10
Abstract: The invention relates to a microbial method of in vitro transformation of a steroid into its corresponding 11'alpha'-hydroxy analogue using oxygen and a microorganism selected from Aspergillus ochraceus, Aspergillus niger, Rhizopus stolonifer, Rhizopus nigricans, Rhizopus arrhizus, and strains of Pestelotia, characterized in that a steroid having a purity of less than 97 % is used.
Patent NZ-331257-A (NZ)
Title: Method of securely modifying data on a smart card
Inventor: DRUPSTEEN MICHEL MARCO PAUL
IPC: G06F21/64
Filed: 1997-03-07
Abstract: The invention pertains to a method of securely transferring data, such as program data, to a smart card. In order to be applicable in non-secure environments, the method of the invention involves a one-way authentication mechanism, comprising the use of a series of interrelated authentication values (R0, R1, R2, ...). Further security is achieved by using commands (INIT, TRAN) which are provided with an authentication code (MAC0, MAC1, ...). In order to transfer data only to selected cards, the card may accept transfer commands only if a card profile (CP) matches a distribution profile (DP).
Patent NZ-332810-A (NZ)
Title: Cigarette package with tear tab on inner wrapper, tear line aligned with edge of package
Inventor: STEWART-COX ADRIAN ROY
IPC: B65D85/10
Filed: 1997-05-02
Abstract: A cigarette packet 50 includes a hinged lid 51 and a flexible inner wrapper 52.  The inner wrapper has a tear line aligned with an edge 54 of the package.  A tear tab 55 is situated adjacent the edge 54 so that it serves as a support for the tab as it is pulled outwardly and along the edge 54.
Patent NZ-334782-A (NZ)
Title: Method and apparatus for making an article from a formable material
Inventor: WESTON TERENCE EDWARD
IPC: A61M5/24
Filed: 1997-09-22
Abstract: A method and apparatus are described for making an article such as the body of a needleless injector capsule, from a formable material, such as glass.  The article has a cavity communicating with the exterior via an orifice.  A blank (1a) having an open end is mounted on a first forming tool, and the open end is engaged by a second forming tool (22) while an end region of the blank (1a) adjacent the open end is in a condition to permit it to be formed.  One of the tools (7a) has a pin (21) extending therefrom, and when the tools are brought together to form the end region into the desired shape the pin (21) defines the orifice.
Patent NZ-503604-A (NZ)
Title: 2-substituted 1,2-benzoisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)
Inventor: BACH ALFRED
IPC: C07D417/06
Filed: 1998-10-05
Abstract: 2-Substituted 1,2-benzisothiazole derivatives of formula (I) and their enantiomers, diastereomers, tautomers and acid salts are disclosed. R1 and R2 are independently C1-6 alkyl; R3 and R4 are independently H, C1-6 alkyl, OH, C1-6 alkoxy, F, Cl, Br, I, CF3, NR5R6, CO2R7, NO2, CN, pyrrolo, or phenyl-(C1-4 alkyl), which may itself be ring-substituted by F, Cl, Br, I, C1-4 alkyl, C1-4 alkoxy, CF3, OH, NH2, CN or NO2; R5 and R6 are independently H, C1-6 alkyl, benzoyl, CO2-tert.-butyl, (C1-4 alkyl)carbonyl or together form a 5- or 6-membered ring, which may contain a second N atom (e.g. piperazinyl); R7 is H or C1-6 alkyl; A is C1-10 alkylene or C2-10 alkylene containing one or more Z groups; Z is O, S, NR7, cyclopropyl, CHOH, or a double or triple bond; B is 4-piperidine, 4-(1,2,3,6-tetrahydropyridine), 4-piperazine or one of these rings N-bound to A via a methylene group; Ar is phenyl (optionally substituted by C1-6 alkyl, C1-6 alkoxy, OH, F, Cl, Br, I, CF3, NR5R6, CO2R7, CN or phenyl), tetralinyl, indanyl, other condensed aromatic moieties e.g. naphthalinyl (optionally substituted by C1-4 alkyl or C1-4 alkoxy), anthracenyl, or a 5- or 6-membered aromatic heterocycle with 1 or 2 O or N heteroatoms, which can be fused with other aromatic groups.
Patent NZ-505928-A (NZ)
Title: Wheelchair and link assembly for use with a wheelchair and so as to alter the horizontal spacing between side frames but not the vertical location of side frames
Inventor: SLAGERMAN MURRAY G
IPC: A61G5/10
Filed: 1999-02-22
Abstract: A wheelchair (10) includes side frame assemblies (12), seat  frame bars (16), a cross-brace assembly (14), and link assemblies  (44)  for  connecting the  cross-brace  assembly (14)  to the side frame assemblies (12). The link assemblies (44)  include an upper link assembly and lower link assembly attaching  to each side frame assembly (12) and  the  cross- brace member (38). The link assemblies (44) enable the  user to  adjust the cross-brace member (38) relative to the  side frame  assemblies  (12)  at  any  one  of  a  plurality   of substantially  horizontally spaced adjustment  points  (84). The   adjustment   points  lack  any  substantial   vertical adjustments.  The  horizontal  points  may   be   spaced   a predetermined   distance  apart  to   enable   a   user   to incrementally  adjust  the spacing between  the  side  frame assemblies (12). Varying the spacing between the side  frame assemblies  (12)  does not affect the  height  of  the  seat frame   bars   (16).   The   link   assemblies   (44)    are interchangeable  from one side frame assembly  (12)  to  the other.
Patent NZ-508048-A (NZ)
Title: Attachment member for fixing a perforated component to a support
Inventor: GONNET LOUIS
IPC: F16B19/14
Filed: 2000-11-08
Abstract: An attachment member to facilitate the fixing of a component to a support.  The attachment member includes a bore (6) for receiving a fixing plug (10), a front support surface (3) intended to be applied to the component (20) to be fixed, and a pin (8) for positioning the attachment member and absorbing the shock caused by the plug (10) striking the attachment member upon fixing.
Patent NZ-508399-A (NZ)
Title: Packaging cell lines for use in facilitating the development of high capacity adenoviral vectors
Inventor: NEMEROW GLEN R
IPC: C12N5/10
Filed: 1997-09-24
Abstract: A packaging cell line expressing an adenovirus structural protein, polypeptide or fragment thereof, selected from a penton base, a hexon, a fiber, a polypeptide IIIa, a polypeptide V, a polypeptide VI, a polypeptide VII, a polypeptide VIII, biologically active fragments thereof, wherein the gene encoding said protein, polypeptide, fragment comprises a tripartite leader sequence.  Also disclosed are viral vectors and compositions of viral vectors, wherein said vectors comprise deletions or mutations of a DNA sequence encoding an adenovirus fiber protein, and wherein said vectors are packaged in said packaging cell lines.
Patent NZ-508938-A (NZ)
Title: Identification and monitoring device attachment using heat shrink encapsulation
Inventor: HEESEN HARMEN JAN
IPC: A01K29/00
Filed: 2000-12-18
Abstract: An animal attachment device that includes an attachment means adapted to attach a secondary device to the tail of an animal, the secondary device being protected in a casing and incorporating an electronic identification means, and wherein the attachment means extends about a section of the animal to secure the secondary device to the animal.
Patent NZ-512712-A (NZ)
Title: New dialysis method using low molecular weight thrombin inhibitors
Inventor: FAGER GUNNAR
IPC: A61M1/14
Filed: 2000-01-11
Abstract: A low molecular weight thrombin inhibitor is used in the manufacture of a medicament for the treatment by dialysis of a patient in need of such treatment, in which the thrombin inhibitor is provided in the dialysing solution. Also disclosed is a dialysis concentrate including a low molecular weight thrombin inhibitor.
Patent NZ-514870-A (NZ)
Title: A device and means for removably securing objects by forming sleeve around object and attaching to surface by vacuum
Inventor: ADJELEIAN MICHAEL JOHN
IPC: F16B47/00
Filed: 2000-03-27
Abstract: Disclosed  is a device for removably securing  a  wide variety  of  objects  to  different  surfaces  utilizing   a partial  vacuum. The device includes flexible  material  (1) comprising one or more opening(s) (2), wherein each  opening is  capable  of forming a continuous seal with a portion  of an  object  (4)  and the remaining material  is  capable  of forming  a continuous seal with a surface (5). The  size  of the  opening  and the size of the material can  vary  within the  constraints that adequate material remains  surrounding the opening to enable a continuous seal to be formed with  a surface  when  an object is inserted into the  opening.  The device  is  used by inserting an object (4) into an  opening (2),  thereby forming a continuous seal between  the  object (4)  and  the opening (2) and pressing the device against  a surface (5), displacing air to create a partial vacuum in  a manner  that  causes a continuous seal to form  between  the flexible  material  (1)  and  the  attachment  surface  (5), thereby  removably securing the object (4)  to  the  surface (5).
Patent NZ-526408-A (NZ)
Title: Promoter sequences upstream of the carp gene, vectors containing them and uses in treating cardiac disorders
Inventor: SCHWARTZ BERTRAND
IPC: A61K35/76
Filed: 2001-12-05
Abstract: A polynucleotide comprises a fragment of the sequence upstream of the coding part of the for the CARP (Cardiac Ankyrin Repeat Protein) protein. The fragment has the sequence of SEQ ID NO:1 and is capable of inducing specific expression in vivo of a gene operably linked to the polynucleotide in cardiac cells. The polynucleotide or vector comprising the polynucleotide can be used in the manufacture of a medicament for the treatment of cardiac insufficiency, cardiac hypertrophy, hypoxia, and for preventing rejection during cardiac transplant.
Patent NZ-528812-A (NZ)
Title: Combined connector for fluid and electrical connection
Inventor: GERGEK FRANC
IPC: H01R13/46
Filed: 2002-03-15
Abstract: A combined connector assembly (10) for fluid and electrical connection comprising: a socket assembly (12) including a socket body (22) having a first end, a second end, and a fluid passage (28) extending through the socket body (22) and forming first and second openings (30,32) in the respective first and second ends, a plurality of metal contacts (38) affixed to the socket assembly (12) and adapted to be connected to a first external circuit; a plug assembly (14) including a plug body (98) having a first end, a second end, and a fluid passage (110) extending through the plug body (98) and forming first and second openings (112,114) in the respective first and second ends, the first end being detachably sealingly received in the first opening of the socket body (22), thereby selectively providing fluid communication of the fluid passage (28) of the socket body (22) with the fluid passage (110) of the plug body (98); a plurality of metal contacts (130) positioned on the plug assembly (14) and adapted to be connected to a second external circuit; and C H A R A C T E R I Z E D by: means for releasably interlocking the plug assembly (14) and the socket assembly (12) in the connected position, the means including a first part (36) incorporated with the metal contacts (38) affixed to the socket assembly (12) and a second part (122) incorporated with the metal contacts (130) positioned on the plug assembly (14), the contacts (38) of the socket assembly (12) and the contacts (130) of the plug assembly (14) being in contact only when the first part (36) engages the second part (122).
Patent NZ-529316-A (NZ)
Title: Pharmaceutically active morpholinol
Inventor: MORGAN PHILLIP FREDERICK
IPC: A61P25/24
Filed: 1999-01-20
Abstract: (+)-(2S,3S)-2-(3-chlorophneyl)-3,5,5-triehtyl-2-morpholinol.
Patent NZ-531856-A (NZ)
Title: Inorganic nanofiltration membranes
Inventor: LESCOCHE PHILIPPE
IPC: B01D69/10
Filed: 2002-09-25
Abstract: An inorganic nanofiltration membrane is disclosed, which comprises: a titanium oxide macroporous support, one or several intermediate separation layers, and an upper metal oxide nanofiltration separation layer.
Patent NZ-533152-A (NZ)
Title: Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms
Inventor: SCHULER ELEANOR
IPC: A61N1/00
Filed: 2002-11-25
Abstract: A device for treating asthma and respiratory disease that selects waveforms from a storage area that are representative of body organ function. The selected waveforms are then transmitted to a treatment member, which is adapted to be in direct contact with the body, and which then broadcasts the waveforms to a specific body organ to modulate the body organ functioning. A control module is provided for transmission to the treatment member. The control module contains the waveforms which are selected and transmitted to the treatment member, and computer storage can be provided for greater storage capacity and manipulation of the waveforms.
Patent NZ-533859-A (NZ)
Title: Improved process for preparation of gabapentin
Inventor: SAIGAL JAGDISH CHAND
Filed: 2002-11-18
Abstract: Disclosed is a process of producing gabapentin, comprising: (i) providing an aqueous alkaline solution of gabapentin hydrochloride salt and reacting with sulphuric acid followed by neutralising with inorganic bases, (ii) filtration of inorganic salts and distillation to obtain a resultant solid, (iii) dissolving the resultant solid of (ii) above in a protic solvent, filtering to removing traces of inorganic salts followed by distillation of the resulting solvent to obtain a residue, (iv) adding another solvent to the residue and isolating gabapentin therefrom by filtration.
Patent NZ-534444-A (NZ)
Inventor: SCHMID ALEXANDRE CURY
IPC: F25D11/02
Filed: 2003-02-18
Abstract: An air duct arrangement for a refrigerator with forced air circulation of the type that comprises a refrigerating compartment (20) provided with a diffusing duct (23) receiving a refrigerated forced airflow from an air cooling compartment (40). The arrangement comprises at least one distributing duct (60) disposed in the upper portion of a space (V) defined below at least one of the shelves (22). The distributing duct (60) presents a rear end opened to the inside of the diffusing duct (23) and a front end opened to the front region of said space (V) adjacent to the front door (21) of the refrigerating compartment (20) and provided with a plurality of front openings (not shown) turned to the front region of said space.
Patent NZ-535203-A (NZ)
Title: A transport trolley having pivotable roller housings
Inventor: RAETZE BERND
IPC: B66F9/075
Filed: 2003-02-12
Abstract: A low-rise trolley to transport palletised cargo 12-18 meters in length and weighing in excess of 30 tonnes has two parallel forks each supported by two or three sets of rollers 7-13. Respective hydraulic cylinders 140 extend and retract each set of rollers 7-13 with respect to its housing 6 so that loads may be lifted by the trolley. Each housing 6 is pivotally mounted at 115 to its respective fork so as to allow rollers 7-13 to remain in contact with uneven ground.
Patent NZ-536097-A (NZ)
Title: Process for producing very low COD unbleached pulp
Inventor: VRBANAC MICHAEL DAVID
Filed: 2002-05-15
Abstract: A process for making a low COD pulp, comprising: a) repetitively soaking and washing unbleached pulp containing sugars and other organic materials in water that is maintained at alkaline conditions such that said pulp is soaked for a total of at least 400 minutes at an elevated temperature to produce a pulp product having the sugars and other organic products reduced such that the pulp product has a COD of less than or equal to 3.0 kg per 1000 kg; b) adding alkali to said pulp while soaking and washing; and c) dewatering and drying said pulp while maintaining said alkaline conditions.
Patent NZ-537965-A (NZ)
Title: Humanized anti-lymphotoxin beta receptor antibodies
Inventor: GARBER ELLEN
IPC: C07K17/08
Filed: 2003-07-01
Abstract: Disclosed are humanized antibodies specific for the lymphotoxin beta receptor (LT-beta-R) cell lines that produce these antibodies, immunochemicals made from the antibodies, and diagnostic methods that use the antibodies. The antibodies are useful for the treatment of cancers including solid tumours.
Patent NZ-538877-A (NZ)
Title: A process and a device for preparing beverages from soluble products
Inventor: MAJER DOGLIONI LUCA
IPC: A47J31/06
Filed: 2002-10-03
Abstract: A method and a device are described for the preparation of a beverage from a soluble product contained in a disposable cartridge, based on the regulation of the dispensing of the beverage in such way that the soluble product is delivered in suspension for at least 75% of the total dispensing time. According to one embodiment said device comprises of the outlet opening of the cartridge (1).
Patent NZ-539840-A (NZ)
Title: Motorized locking mechanism
Inventor: NUNEZ PAUL
IPC: E05B47/00
Filed: 2003-11-12
Abstract: A motorized locking mechanism is disclosed for locking and unlocking a device having a hub rotatable by a handle about a hub axis. A reversible motor turns a threaded spring screw to move a locking spring and vertically drive a connecting arm between locked and unlocked positions. A locking slide is mounted on an end of the connecting arm so that it can pivot parallel to the hub axis. As the motor drives the connecting arm to the locked position, the locking slide moves into interfering engagement with the hub to lock the device. The pivoting motion of the locking slide protects the locking mechanism, and particularly the connecting arm, against damaging forces that can be applied by the rotating hub through the locking slide. If the locking slide is temporarily prevented from moving into or out of locking engagement with the hub, the motor may still turn and the locking spring subsequently moves the locking slide in the desired direction without the necessity of reactivating the motor. The locking spring characteristics and mounting, and the pitch of the spring screw threads, are selected so that the connecting arm and locking slide may be lifted and continuously supported vertically.
Patent NZ-541096-A (NZ)
Title: Complex interactive function in a reproduction-dedicated optical disk via a virtual player model corresponding to a player function built and described by java
Inventor: HAMADA TOSHIYA
IPC: G11B27/034
Filed: 2004-08-19
Abstract: A reproducing apparatus that reproduces content data hierarchically recorded on a disc-shaped recording medium comprises: a player object that generates an event corresponding to a predetermined change; and a program object that is formed above the player object and that is capable of describing a process corresponding to the event that takes place. The player object controls a reproduction process for content data hierarchically recorded on the disc-shaped recording medium with a process corresponding to the event described in the program object. The program object is reproduced from the recording medium. When the program object registers a process corresponding to the event that takes place to the player object, the player object executes the process corresponding to the event that takes place. The predetermined change is a change that takes place while the content data is being reproduced. The predetermined change is detection of a mark that represents a time that is set in the content data. The reproducing apparatus further comprising user input means for receiving a user input and informing the player object of the user input.
Patent NZ-541132-A (NZ)
Title: Containers and closures for containers
Filed: 2005-07-06
Abstract: A container comprises a container body 1 having a mouth and a lip. A collar 5 made from pliable material can be permanently attached to the body 1 by means of the lip. A closure 7 is also attachable to the container.
Patent NZ-541807-A (NZ)
Title: UV stable transdermal therapeutic plaster
Inventor: SCHUMACHER JOCHEN
IPC: A61K47/22
Filed: 2004-02-04
Abstract: Disclosed is a transdermal therapeutic system (TTS) consisting of a backing layer, of at least one active ingredient containing matrix and optionally of a detachable sheet, and comprising a UV absorber, characterized in that at least one UV absorber-containing adhesive layer is provided between the backing layer and the active ingredient-containing matrix which is furthest away from the surface of the skin, at least one separating layer which is impermeable to the active ingredient and impermeable to the UV absorber is present between the adhesive layer containing the UV absorber and the active ingredient-containing matrix which is furthest away from the surface of the skin. The transdermal therapeutic system can be further characterised in that the sequence of layers in the system starting from the side facing away from the skin is backing layer, UV absorber-containing adhesive layer, separating layer and finally a mono- or bilayer active ingredient-containing matrix whose pressure-sensitive adhesive surface is covered by a detachable protective sheet.